McElhenny Sheffield Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
HCM
McElhenny Sheffield Capital Management's ABBV Position: Q2 2026 in Review
McElhenny Sheffield Capital Management increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $61.7K and bringing the position to 3,094 shares worth $779K. The position accounts for 0.19% of the portfolio, ranked #24.
McElhenny Sheffield Capital Management first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.61M in Q2 2022. 1,681 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- McElhenny Sheffield Capital Management held 3,094 shares of AbbVie worth $779K as of Q2 2026.
- McElhenny Sheffield Capital Management bought 287 AbbVie shares in Q2 2026, an estimated $61.7K.
- AbbVie made up 0.19% of McElhenny Sheffield Capital Management's portfolio in Q2 2026, its #24 holding.
- McElhenny Sheffield Capital Management first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
- McElhenny Sheffield Capital Management's AbbVie position peaked at $2.61M in Q2 2022.
- 1,681 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on McElhenny Sheffield Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.